{
     "PMID": "17325649",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20070629",
     "LR": "20171116",
     "IS": "0007-1188 (Print) 0007-1188 (Linking)",
     "VI": "150",
     "IP": "7",
     "DP": "2007 Apr",
     "TI": "5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j mice.",
     "PG": "883-92",
     "AB": "BACKGROUND AND PURPOSE: A strategy to treat Alzheimer's disease (AD) is to increase the soluble form of amyloid precursor protein (sAPPalpha), a promnesic protein, in the brain. Because strong evidence supports beneficial effects of 5-hydroxytryptamine 5-HT(4) receptor agonists in memory and learning, we investigated the role of 5-HT(4) receptors on APP processing in 8 weeks-old male C57BL/6j mice. EXPERIMENTAL APPROACH: Mice were given, subcutaneously, prucalopride or ML 10302 (s.c.), two highly selective 5-HT(4) receptor agonists and, up to 240 min later, the hippocampus and cortex were analysed by Western blot for sAPPalpha determination. KEY RESULTS: Prucalopride (5 or 10 mg kg(-1)) significantly increased sAPPalpha levels in the hippocampus and cortex, but did not modify the expression level of APP mRNA as detected by quantitative RT-PCR. A selective 5-HT(4) receptor antagonist, GR125487 (1 mg kg(-1), s.c.) inhibited prucalopride induced- increase in sAPPalpha levels. In addition, levels of sAPPalpha were increased by ML10302 only at 20 mg kg(-1) and was limited to the cortex. Also, prucalopride increased sAPPalpha levels in the cortex of a transgenic mouse model of AD, expressing the London mutation of APP. Furthermore, the combined injection of a selective acetylcholinesterase inhibitor, donepezil and prucalopride induced a synergic increase in sAPPalpha levels in the cortex and hippocampus. CONCLUSIONS AND IMPLICATIONS: Our results demonstrate that the 5-HT(4) receptor plays a key role in the non-amyloidogenic pathway of APP metabolism in vivo and give support to the beneficial use of 5-HT(4) agonists for AD treatment.",
     "FAU": [
          "Cachard-Chastel, M",
          "Lezoualc'h, F",
          "Dewachter, I",
          "Delomenie, C",
          "Croes, S",
          "Devijver, H",
          "Langlois, M",
          "Van Leuven, F",
          "Sicsic, S",
          "Gardier, A M"
     ],
     "AU": [
          "Cachard-Chastel M",
          "Lezoualc'h F",
          "Dewachter I",
          "Delomenie C",
          "Croes S",
          "Devijver H",
          "Langlois M",
          "Van Leuven F",
          "Sicsic S",
          "Gardier AM"
     ],
     "AD": "EA3544, Serotonine et Neuropharmacologie, Faculte de Pharmacie, Universite Paris-Sud, Chatenay-Malabry cedex, France.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20070226",
     "PL": "England",
     "TA": "Br J Pharmacol",
     "JT": "British journal of pharmacology",
     "JID": "7502536",
     "RN": [
          "0 (2-piperidinoethyl 4-amino-5-chloro-2-methoxybenzoate)",
          "0 (Aminobenzoates)",
          "0 (Amyloid beta-Protein Precursor)",
          "0 (Benzofurans)",
          "0 (Cholinesterase Inhibitors)",
          "0 (Indans)",
          "0 (Indoles)",
          "0 (Piperidines)",
          "0 (RNA, Messenger)",
          "0 (Serotonin 5-HT4 Receptor Agonists)",
          "0 (Serotonin 5-HT4 Receptor Antagonists)",
          "0 (Serotonin Antagonists)",
          "0 (Serotonin Receptor Agonists)",
          "0 (Sulfonamides)",
          "0 (para-Aminobenzoates)",
          "0A09IUW5TP (prucalopride)",
          "8SSC91326P (donepezil)",
          "ZT350OYT3I (GR 113808)"
     ],
     "SB": "IM",
     "MH": [
          "Aminobenzoates/pharmacology",
          "Amyloid beta-Protein Precursor/*biosynthesis/genetics",
          "Animals",
          "Benzofurans/pharmacology",
          "Cerebral Cortex/drug effects/*metabolism",
          "Cholinesterase Inhibitors/pharmacology",
          "Hippocampus/drug effects/*metabolism",
          "Indans/pharmacology",
          "Indoles/pharmacology",
          "Male",
          "Mice",
          "Mice, Inbred C57BL",
          "Mice, Transgenic",
          "Piperidines/pharmacology",
          "RNA, Messenger/metabolism",
          "*Serotonin 5-HT4 Receptor Agonists",
          "Serotonin 5-HT4 Receptor Antagonists",
          "Serotonin Antagonists/pharmacology",
          "Serotonin Receptor Agonists/pharmacology",
          "Sulfonamides/pharmacology",
          "para-Aminobenzoates"
     ],
     "PMC": "PMC2013878",
     "EDAT": "2007/02/28 09:00",
     "MHDA": "2007/06/30 09:00",
     "CRDT": [
          "2007/02/28 09:00"
     ],
     "PHST": [
          "2007/02/28 09:00 [pubmed]",
          "2007/06/30 09:00 [medline]",
          "2007/02/28 09:00 [entrez]"
     ],
     "AID": [
          "0707178 [pii]",
          "10.1038/sj.bjp.0707178 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Br J Pharmacol. 2007 Apr;150(7):883-92. doi: 10.1038/sj.bjp.0707178. Epub 2007 Feb 26.",
     "term": "hippocampus"
}